Martin Shkreli can't catch a break.
After being arrested earlier this month in a fraud investigation, Shkreli's drug company, KaloBios, filed for Chapter 11 Bankruptcy Tuesday.
The bankruptcy filing says the company seeks emergency protection and needs about $56,000 to fulfill its payroll obligations by Dec. 31, according to Vanity Fair.
>> FBI tweets 'didn't seize Wu-Tang album' in Shrkeli arrest
Shkreli tried to revive the company in November and was briefly successful in doing so. After he was named CEO, its shares rebounded from less than $1 to nearly $40.
The former drug company CEO and hedge fund manager posted a $5 million bond and is currently awaiting his next court appearance on Jan. 20, 2016.
Click here to read more.
About the Author
The Latest
Featured
